| Literature DB >> 26196127 |
Taweewat Wiangkham1, Joan Duda1, Sayeed Haque2, Mohammad Madi1, Alison Rushton1.
Abstract
OBJECTIVE: To evaluate the effectiveness of conservative management (except drug therapy) for acute Whiplash Associated Disorder (WAD) II.Entities:
Mesh:
Year: 2015 PMID: 26196127 PMCID: PMC4511004 DOI: 10.1371/journal.pone.0133415
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Eligibility criteria.
|
| Acute (<4 weeks) WADII (0-II or I-II participants were included when the grade was not classified in study) |
|
| Conservative treatment (inclusive of the range of intervention detailed as part of the search strategy in search stages 3–20, and excluding drug therapy) |
|
| Standard/control intervention |
|
| Clinical relevant outcomes base on the International Classification of Function, Disability and Health (ICF) |
|
| Randomised controlled trial |
Fig 1Study selection flow diagram.
Summary results from the 15 included trials.
| Studies | Countries | N | WAD | Design | Intervention 1 | Intervention 2 | Intervention 3 | Outcome Measures | Follow-up period | Main Results |
|---|---|---|---|---|---|---|---|---|---|---|
| Aigner et al. 2006 [ | Austria | 53 | II | Parallel RCT with single blind | Collar and laser acupuncture | Collar and placebo laser acupuncture | - | -CROM,Subjective symptoms (neck pain, dizziness, paresthesia and tinnitus),Sick leave | 3 weeks (Clinically)8-12 Months (Postal) | No significant difference between interventions in all outcome measures |
| Bonk et al. 2000 [ | Germany | 147 | 0-II | Parallel RCT | Active therapy (active mobilization and exercise) | Collar therapy | Control | -Subjective symptoms (such as pain, stiffness), CROM | 3 months | No significant difference between interventions at 3 months |
| Borchgrev-ink et al. 1998 [ | Norway | 201 | 0-II | Parallel RCT with single blind | Act-as-usual | Immobilisati-on | - | -Subjective symptoms using questionnaire, Pain (VAS), CROM, Shoulder movement, Sick leave | 6 months | I1>I2 significantly in improvement neck pain (p<0.01), pain during daily activities (p< 0.05), headaches (p<0.01), painful regions (p<0.01), and memory and concentration problems (p<0.001) at 6 months. ROM of neck and shoulder did not differ between interventions. |
| Conforti and Fachinetti 2013 [ | Italy | 135 | I-II | Parallel RCT with single blind | HPLT | PT (manual therapy, passive and active exercise) | - | -Pain (VAS), The date of return to work | 6 weeks | I1 > I2significantly improved in both pain (p = 0.005) and the date of return to work (p<0.001) |
| Dehner et al. 2006 [ | Germany | 70 | II | Parallel RCT | 2 days with collar + standard PT after a weeks | 10 days with collar + standard PT after a weeks | - | -Pain (VAS), Disability (VAS), CROM | 6 months | No significant difference between interventions in all outcome measures |
| Dehner et al. 2009 [ | Germany | 90 | II | Parallel RCT | Active physical therapy | Passive physical therapy | Act as usual | -Pain (VAS), CROM, Period of disability/ sickness costs | 2 months | - Pain improvement: I1>I2>I3 significantly- CROM: I1 = I2 = I3- Period of disability: I1 = I2<I3 |
| Ferrari et al. 2005 [ | Canada | 112 | I-II | Parallel RCT with single blind | Education pamphlet | Control group | - | -The number of recovery | 3 months | No significant difference between interventions |
| Foley-Nolan et al. 1992 [ | Ireland | 40 | 0-II | Parallel RCT with single blind | PEMT + collar + active exercise | Placebo + collar + active exercise | - | -Pain (VAS), CROM, Number of analgesics | 3 months | I1>I 2 significantly improved in terms of pain (VAS) at 2 and 4 weeks but no significance at 12 weeks. For the CROM, I1>I2 significantly at 3 months (p<0.001). |
| Jull et al. 2013 [ | Australia | 101 | II | Parallel RCT with single blind | Multiprofess-ional intervention | Usual care | - | -Pain (VAS), NDI, IES, PFActS-C, GHQ 28, CROM, Craniocervical flexor test, Balance, Cervical proprioception, PPT, HPT, CPT, Sympathetic vasoconstrictor response, Types and dosage of medications | 12 months | No significant difference between interventions in all outcome measures but the recovery of pain and disability between baseline, 6 and 12 months has significant differences in both interventions. |
| Ottosson et al. 2007 [ | Sweden | 127 | I-II | Parallel RCT with unblind | Educational programme + self-care (exercise for relaxation and postural control) | Standard Rx.(basic medications) | - | -Self-reported recovery, SF-36, SMFA, Pain and mental distress (VAS), Sick leave | 12 months | I1>I2 significantly in terms of self-reported recovery (p<0.03) but no significant difference in other outcomes between interventions |
| Picelli et al. 2011 [ | Italy | 18 | I-II | Parallel RCT with single blind | Neck fascia manipulation | Neck mobilization exercise + stretching | - | -CROM, Pain (VAS), NDI, PPT | 2 weeks | CROM: I1>I2 significantly (p<0.01) but other outcome measures, no significant differences between interventions. |
| Rosenfeld et al. 2003 [ | Sweden | 102 | 0-II | Parallel RCT with single blind | Active mobilization within 96 hours or Active mobilization 14 days | Standard Rx. (rest, collar and gradual self-mobil)within 96 hrs or Standard Rx. (rest, collar and gradual self-mobil) 14 days | - | -Pain (VAS), CROM, Sick leave | 3 years | Pain and sick leave I1<I2 significantly (p<0.05) but no significance in CROM (p = 0.06–0.08) |
| Schnabel et al. 2004 [ | Germany | 200 | I-II | Parallel RCT with un- blind | Mobilisation exercise | Collar therapy | - | -Pain (VAS), Disability (VAS) | 6 weeks | I1>I2 significantly in improving pain and disability (p<0.05) |
| Scholten-Peerters et al. 2006 [ | Netherlands | 80 | I-II | Parallel RCT with single blind | Education and exercise by PTs | Education by GPs | - | -Pain (VAS), Functional recovery (VAS), SF-36, CROM, TSK, PCI, NDI, Disability in housekeeping and social activities (VAS) | 13 months | At 12 weeks, I1>I2 significantly for CROM improvement but in long term I2>I1 significantly in terms of functional recovery, coping, and physical functioning. |
| Vassiliou et al. 2006 [ | Germany | 200 | I-II | Parallel RCT with unblind | PT + active exercise | Standard Rx (drugs + soft collar) | - | -Pain and disability (NRS), Number of days with oral medication, The period of soft collar | 6 months | I1>I2 significantly improved in terms of pain intensity and disability. Other outcomes had been reported but no compare using statistic procedure. |
CPT: Cold Pain Threshold, CROM: Cervical Range of Motion, GHQ 28: General Health Questionnaire, HPLT: High Power Laser Therapy, HPT: Hot Pain Threshold, I: Intervention, IES: Impact of Events Scale, NDI: Neck Disability Index, NRS: Numeric Rating Scale, PCI: Pain Coping Inventory, PFActS-C: Pictorial Fear of Activity Scale-Cervical, PPT: Pressure Pain Thresholds, PT: Physiotherapy, RCT: Randomised Controlled Trail, Rx: Treatment, SMFA: Short Musculoskeletal Function Assessment, SF-36: Functional Health Status (Short Form 36), TSK: Tampa Scale for Kinesiophobia, VAS: Visual Analogue Scale
Summary of risk of bias assessment [61].
| Studies | Components of risk of bias | Summary risk of bias | Overall RoB | Comments, high risk components | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5a | 5b | 6 | ||||
| Aigner et al. 2006 [ | U | U | U | L | H | H | H | High (3) Unclear (3) Low (1) | H | Three high component: 5a, 5b, 6 (5a: No primary outcomes pre-specified, 5b: No primary outcomes pre-specified, 6: No primary endpoint specified and No ITT reported) |
| Bonk et al. 2000 [ | U | U | H | L | H | N/A | H | High (3) Unclear (2) Low (1) N/A (1) | H | Three high component: 3, 5a, 6 (3: Unblind assessors, 5a: No primary outcomes pre-specified, 6: No primary endpoint specified and No ITT reported) |
| Borchgrevink et al. 1998 [ | U | U | L | H | U | N/A | H | High (2) Unclear (3) Low (1) N/A (1) | H | Two high component: 4, 6 (4: loss follow-up >16 without stating of which group, 6: No primary endpoint specified and No ITT reported) |
| Conforti and Fachinetti 2013 [ | U | U | L | L | H | N/A | H | High (2) Unclear (2) Low (2) N/A (1) | H | Two high component: 5a, 6 (5a: No primary outcomes pre-specified, 6: No primary endpoint specified, No ITT reported and No statistical analysis reported) |
| Dehner et al. 2006 [ | L | L | U | L | H | N/A | H | High (2) Unclear (1) Low (3) N/A (1) | H | Two high component: 5a, 6 (5a: No primary outcomes pre-specified, 6: No primary endpoint specified and No ITT reported) |
| Dehner et al. 2009 [ | L | L | U | U | H | N/A | H | High (2) Unclear (2) Low (2) N/A (1) | H | Two high component: 5a, 6 (5a: No primary outcomes pre-specified, 6: No primary endpoint specified and No ITT reported) |
| Ferrari et al. 2005 [ | L | L | L | H | L | N/A | H | High (2) Unclear (1) Low (4) N/A (1) | H | Two high component: 4, 6 (4: reasons of drop-out were not reported, 6: No primary endpoint specified and No ITT reported) |
| Foley-Nolan et al. 1992 [ | U | U | U | L | H | N/A | H | High (2) Unclear (3) Low (1) N/A (1) | H | Two high component: 5a, 6 (5a: No primary outcomes pre-specified, 6: No primary endpoint specified and No ITT reported) |
| Jull et al. 2013 [ | L | L | L | U | L | L | H | High (1) Unclear (1) Low (5) | H | One high component: 6 (No ITT and Pain (VAS) has reported in significant difference between group at baseline) |
| Ottosson et al. 2007 [ | L | L | H | L | N/A | L | H | High (2) Low (4) N/A (1) | H | Two high component: 3, 6 (3: Unblind, 6: No primary endpoint specified) |
| Picelli et al. 2011 [ | L | U | L | L | H | N/A | H | High (2) Unclear (2) Low (3) N/A (1) | H | Two high component: 5a, 6 (5a: P-value did not report in NDI and PPT, 6: No primary endpoint specified and No ITT reported) |
| Rosenfeld et al. 2003 [ | L | L | L | H | H | H | H | High (4) Low (3) | H | Four high component: 4, 5a, 5b, 6 (4: drop-out difference between groups, 5a: No primary outcomes pre-specified, 5b: No primary outcomes pre-specified, Reporting sick leave but have not stated, 6: No primary endpoint specified and No ITT reported) |
| Schnabel et al. 2004 [ | U | U | U | H | H | N/A | H | High (3) Unclear (3) N/A (1) | H | Three high component: 4, 5a, 6 (4: Loss of follow-up: A = 36%, B = 15%, 5a: No primary outcomes pre-specified, 6: No primary endpoint specified and No ITT reported) |
| Scholten-Peeters et al. 2006 [ | L | L | L | L | L | L | H | High (1) Low (6) | H | One high component: 6 (No primary endpoint specified) |
| Vassiliou et al. 2006 [ | L | L | L | L | L | N/A | H | High (1) Low (4) N/A (5) | H | One high component: 6(No primary endpoint specified) |
1 = Sequence generation, 2 = Allocation concealment, 3 = Blinding of participants, personnel and assessors, 4 = Incomplete outcome data, 5a = Selecting outcome reporting (Short term), 5b = Selecting outcome reporting (Long term), 6 = Other potential threats to validity, L = low risk of bias, H = high risk of bias, U = unclear risk of bias, N/A = not applicable
Summary meta-analyses.
| Meta-analyses | I2 (%) | 95% Confidence Interval (CI) | p-value |
|---|---|---|---|
|
| |||
| Pain intensity (VAS) | |||
| at <3 months | 70.0 | -12.90, 2.19 | 0.164 |
| at 6 months | 63.8 | -20.14, -3.38 | 0.005 |
| at 1–3 years | 0.0 | -25.44, -3.19 | 0.012 |
| CROM in sagittal plane | |||
| at 6 months | 10.9 | -3.61, 9.17 | 0.394 |
| at 3 years | 60.5 | -7.78, 27.69 | 0.271 |
| CROM in coronal plane | |||
| at <3 months | 64.2 | -5.78, 6.48 | 0.911 |
| at 6 months | 0.0 | -1.89, 6.42 | 0.285 |
| at 3 years | 64.1 | -5.83, 16.99 | 0.338 |
| CROM in horizontal plane | |||
| at < 3 months | 0.0 | 0.43, 5.60 | 0.022 |
| at 6 months | 55.1 | -16.04, 8.48 | 0.545 |
| at 3 years | 19.0 | -6.80, 16.51 | 0.415 |
| Sick leave (days) | 0.0 | -39.02, 3.83 | 0.107 |
|
| |||
| Pain intensity (VAS) | |||
| at <3 months | 76.3 | -10.51, 6.07 | 0.599 |
| at 6 months | 56.9 | -17.19, -3.23 | 0.004 |
| at 1–3 years | 0.0 | -26.39, -10.08 | < 0.001 |
| CROM in sagittal plane | |||
| at <3 months | 80.6 | -17.73, 8.69 | 0.452 |
| at 6 months | 0.0 | -1.69, 8.44 | 0.192 |
| at 3 years | 60.5 | -7.78, 27.69 | 0.271 |
| CROM in coronal plane | |||
| at <3 months | 82.2 | -6.94, 6.15 | 0.905 |
| at 6 months | 0.0 | -1.13, 5.99 | 0.180 |
| at 3 years | 64.1 | -6.83, 16.99 | 0.338 |
| CROM in horizontal plane | |||
| at <3 months | 85.2 | -8.96, 12.35 | 0.755 |
| at 6 months | 69.4 | -11.28, 12.81 | 0.892 |
| at 3 years | 19.0 | -6.80, 16.51 | 0.415 |
| Sick leave (days) | 0.0 | -39.02, 3.83 | 0.107 |
|
| |||
| Pain intensity (VAS) | |||
| at 6 weeks | 70.0 | -12.90, 2.19 | 0.164 |
| at 6 months | 44.2 | -15.37, -1.55 | 0.016 |
| CROM in coronal plane | |||
| at 3–6 months | 0.0 | 0.93, 4.38 | 0.003 |
| CROM in horizontal plane | |||
| at 3–6 months | 0.0 | 0.43, 5.46 | 0.027 |
|
| |||
| Pain intensity (VAS) | |||
| at 6 months | 79.2 | -25.74, 18.21 | 0.737 |
| at 3 years | 0.0 | -12.51, 9.85 | 0.816 |
| CROM in sagittal plane | |||
| at 6 months | 51.3 | -13.16, 17.02 | 0.802 |
| at 3 years | 60.5 | -11.35, 24.04 | 0.482 |
| CROM in coronal plane | |||
| at 6 months | 27.0 | -8.93, 6.92 | 0.803 |
| at 3 years | 64.0 | -12.95, 9.96 | 0.799 |
| CROM in horizontal plane | |||
| at 6 months | 75.9 | -20.66, 27.31 | 0.786 |
| at 3 years | 19.1 | -4.86, 20.25 | 0.230 |
| Sick leave (days) | 0.0 | -13.37, 28.40 | 0.481 |
* Statistical significance (p < 0.05)
Fig 2Conservative versus standard/control interventions for VAS (pain intensity).
Fig 3Conservative versus standard/control interventions for cervical horizontal movement at <3 months.
Fig 4Active versus passive interventions for VAS (pain intensity).
Fig 5Behavioural versus standard/control interventions for VAS (pain intensity).
Fig 6Behavioural versus standard/control interventions for cervical movement.